We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
Cap. Flow
-$355M
Cap. Flow %
-11.42%
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$28.9M
2
CVS icon
CVS Health
CVS
+$27.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$25M
4
UNH icon
UnitedHealth
UNH
+$20.4M
5
CRM icon
Salesforce
CRM
+$18.8M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$43.8M
2
EWJ icon
iShares MSCI Japan ETF
EWJ
+$42.6M
3
KO icon
Coca-Cola
KO
+$40M
4
ILMN icon
Illumina
ILMN
+$31.6M
5
HAIN icon
Hain Celestial
HAIN
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 17.53%
3 Consumer Discretionary 16.73%
4 Industrials 11.77%
5 Energy 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBH icon
401
Sally Beauty Holdings
SBH
$1.51B
-310,950
Closed -$9.82M
SCOR icon
402
Comscore
SCOR
$76.5M
-13,552
Closed -$14.4M
SIG icon
403
Signet Jewelers
SIG
$3.93B
-26,275
Closed -$3.37M
UTHR icon
404
United Therapeutics
UTHR
$21.5B
-54,140
Closed -$9.42M
VRNT
405
DELISTED
Verint Systems
VRNT
-530,501
Closed -$16.4M
WMB icon
406
Williams Companies
WMB
$87.1B
-102,245
Closed -$5.87M
WT icon
407
WisdomTree
WT
$3.39B
-784,510
Closed -$17.2M
XPO icon
408
XPO
XPO
$20.3B
-1,015,356
Closed -$15.9M
ZBRA icon
409
Zebra Technologies
ZBRA
$16.4B
-137,070
Closed -$15.2M
NVRO
410
DELISTED
NEVRO CORP.
NVRO
-137,490
Closed -$7.39M
INFN
411
DELISTED
Infinera Corporation Common Stock
INFN
-310,817
Closed -$6.52M
SLCA
412
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-170,700
Closed -$5.01M
PACW
413
DELISTED
PacWest Bancorp
PACW
-282,286
Closed -$13.2M
AMAG
414
DELISTED
AMAG Pharmaceuticals
AMAG
-232,613
Closed -$16.1M
MNK
415
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-33,525
Closed -$3.95M
ASNA
416
DELISTED
Ascena Retail Group, Inc.
ASNA
-31,469
Closed -$10.5M
AAC
417
DELISTED
AAC Holdings
AAC
-113,464
Closed -$4.94M
BID
418
DELISTED
Sotheby's
BID
-75,950
Closed -$3.44M
EMES
419
DELISTED
Emerge Energy Services LP
EMES
-32,700
Closed -$1.18M
WFT
420
DELISTED
Weatherford International plc
WFT
-315,100
Closed -$3.87M
CUDA
421
DELISTED
Barracuda Networks, Inc.
CUDA
-165,766
Closed -$6.57M
HSNI
422
DELISTED
HSN, Inc.
HSNI
-215,105
Closed -$15.1M
ABCO
423
DELISTED
Advisory Board Co
ABCO
-281,400
Closed -$15.4M
LVLT
424
DELISTED
Level 3 Communications Inc
LVLT
-42,225
Closed -$2.22M
PLKI
425
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
-142,355
Closed -$8.54M

Similar funds

Castleark Management's Q3 2015 Portfolio in Review

As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.

  • Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
  • Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
  • Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
  • Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
  • Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
  • Castleark Management opened 67 new positions and closed 71 in Q3 2015.
  • Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.

Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.